#Flash: BNT162b2 Vaccine Safe For Individuals With Allergies
Get authentic, real-time news that helps you fight COVID-19 better.
Install PlexusMD App for doctors. It's free.
A study was carried out to see adverse reactions of Covid 19 among students with allergies using questionnaires. Responses from participants after receiving BNT162b2 vaccine showed that the frequency and severity of the most adverse reactions were more after the second dose and females and younger individuals experienced adverse reactions at a higher rate. Also, the subjects with a history of allergies experienced some adverse reactions with higher severity, and the duration of symptoms lasted for a longer period compared to subjects without any allergies, although none experienced anaphylaxis. This result indicated that no serious life-threatening allergic reactions occurred among the subjects, despite having a history of allergy, post BNT162b2 vaccination.

If you find this post insightful, please like, comment and share.

For more details, please read:
Dr. T●●●●z H●●●●●●i and 1 others like this